BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia M, Zhang H, Wang L, Zhao L, Fan S, Xi Y. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia. Hematology 2021;26:284-94. [PMID: 33648435 DOI: 10.1080/16078454.2021.1889158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao C, Wang Y, Sharma A, Wang Z, Zheng C, Wei Y, Wu Y, Liu P, Liu J, Zhan X, Schmidt-Wolf I, Tu F. Identification of the integrated prognostic signature associated with immuno-relevant genes and long non-coding RNAs in acute myeloid leukemia. Cancer Invest 2022;:1-25. [PMID: 35770858 DOI: 10.1080/07357907.2022.2096230] [Reference Citation Analysis]
2 Xu J, Dong X, Wang R, Chen B. DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target. Front Med 2022;9:842383. [DOI: 10.3389/fmed.2022.842383] [Reference Citation Analysis]
3 Dai C, Chen M, Wang C, Hao X. Deconvolution of Bulk Gene Expression Profiles with Single-Cell Transcriptomics to Develop a Cell Type Composition-Based Prognostic Model for Acute Myeloid Leukemia. Front Cell Dev Biol 2021;9:762260. [PMID: 34869351 DOI: 10.3389/fcell.2021.762260] [Reference Citation Analysis]
4 Ma H, Liu J, Li Z, Xiong H, Zhang Y, Song Y, Lai J. Expression profile analysis reveals hub genes that are associated with immune system dysregulation in primary myelofibrosis. Hematology 2021;26:478-90. [PMID: 34238135 DOI: 10.1080/16078454.2021.1945237] [Reference Citation Analysis]